TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33710921

Group type: EXPERIMENTAL
Intervention: Short-axis out-of-plane technique
Number of subjects: 80

Group type: COMPARATOR
Intervention: Long-axis in-plane technique
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 80
Study: 34462262

Group type: EXPERIMENTAL
Intervention: Baseline local joint swelling
Number of subjects: 508
Study: 33765904

Group type: EXPERIMENTAL
Intervention: Multi-strain synbiotic (n=54)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Simethicone (n=33)
Number of subjects: 87
Study: 32624377

Group type: EXPERIMENTAL
Intervention: Transdermal buprenorphine patch (10 μg/h)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Oral celecoxib
Number of subjects: 160
Study: 36103665

Group type: EXPERIMENTAL
Intervention: Restylane Lyft (1 ml on day 1, re-treatment of 0.5 ml at month 12)
Number of subjects: 132

Group type: COMPARATOR
Intervention: No-treatment control (1 ml offered at month 6)
Number of subjects: 132
Study: 33798509

Group type: EXPERIMENTAL
Intervention: Dextrose gel (200 mg/kg)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Any dose of dextrose gel
Number of subjects: 133

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 133
Study: 32379673

Group type: EXPERIMENTAL
Intervention: Sheetali pranayama (intervention group, n = 50)
Number of subjects: 100

Group type: COMPARATOR
Intervention: HTN without pranayama (control group, n = 50)
Number of subjects: 100
Study: 35144326

Group type: EXPERIMENTAL
Intervention: Treatment as usual + Rhemercise (n=63)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Treatment as usual only (n=63)
Number of subjects: 126
Study: 34874419

Group type: EXPERIMENTAL
Intervention: High-flow oxygen therapy through a nasal cannula
Number of subjects: 220

Group type: COMPARATOR
Intervention: Conventional oxygen therapy
Number of subjects: 220
Study: 33957377

Group type: EXPERIMENTAL
Intervention: Modified maximum transverse diameter approach
Number of subjects: 536

Group type: EXPERIMENTAL
Intervention: CT scans interpreted by six volunteer radiologists
Number of subjects: 536

Group type: EXPERIMENTAL
Intervention: CTLungCa-500 dataset markup
Number of subjects: 536

Group type: EXPERIMENTAL
Intervention: Markup process duration
Number of subjects: 536
Study: 36752479

Group type: EXPERIMENTAL
Intervention: Exercise intervention (home and supervised aerobic exercise over 6 months)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 120
Study: 33642340

Group type: EXPERIMENTAL
Intervention: 1000 mg Vitamin C
Number of subjects: 24
Study: 32580979

Group type: EXPERIMENTAL
Intervention: Transition Readiness and Appropriateness Measure (TRAM)
Number of subjects: 1000
Study: 34518950

Group type: EXPERIMENTAL
Intervention: Stapled transection (Endo GIA Reinforced Reload with Tri‐Staple Technology)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Ultrasonic transection (Harmonic Focus + or Harmonic Ace + shears)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Stapled transection
Number of subjects: 145

Group type: COMPARATOR
Intervention: Ultrasonic transection
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 145
Study: 33351209

Group type: EXPERIMENTAL
Intervention: UVB microphototherapy 300 to 320 nm (Bioskin©) 1 x week
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: VITILSI© gel 2 x day
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: VITILSI© gel 2 x day + Bioskin© 1 x week
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo 2 x day
Number of subjects: 40
Study: 35302901

Group type: EXPERIMENTAL
Intervention: Intraoperative injection of autologous microfragmented adipose tissue
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (no injection of autologous microfragmented adipose tissue)
Number of subjects: 44
Study: 34695399

Group type: EXPERIMENTAL
Intervention: En face optical coherence tomography (OCT) assessment of ellipsoid zone (EZ) recovery
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Change in hyporeflective area
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Duration of macula-off
Number of subjects: 61
Study: 33221969

Group type: EXPERIMENTAL
Intervention: Chemotherapy + nintedanib
Number of subjects: 24

Group type: COMPARATOR
Intervention: Chemotherapy + placebo
Number of subjects: 24
Study: 32696120

Group type: EXPERIMENTAL
Intervention: Educational video on infant crying and the dangers of shaking and smothering
Number of subjects: 4722

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 4722
Study: 33632249

Group type: EXPERIMENTAL
Intervention: BioFire assay
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: QuickVue rapid test
Number of subjects: 0

Group type: COMPARATOR
Intervention: qPCR
Number of subjects: 0
Study: 32384478

Group type: EXPERIMENTAL
Intervention: S‐1 combined with XiangShaLiuJunZi decoction (XSLJZD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: S‐1
Number of subjects: 0
Study: 32535646

Group type: EXPERIMENTAL
Intervention: 1 mg intravenous adrenaline
Number of subjects: 8016

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 8016

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 8016
Study: 33597283

Group type: EXPERIMENTAL
Intervention: Checklist access during crisis management
Number of subjects: 138

Group type: COMPARATOR
Intervention: No checklist access during crisis management
Number of subjects: 138
Study: 32698123

Group type: EXPERIMENTAL
Intervention: α-lactalbumin (LA) 40 g
Number of subjects: 12

Group type: COMPARATOR
Intervention: Collagen peptide (CP) 40 g
Number of subjects: 12
Study: 35439293

Group type: EXPERIMENTAL
Intervention: Rituximab plus bendamustine (R-B)
Number of subjects: 329

Group type: COMPARATOR
Intervention: R-CHOP/R-DHAP
Number of subjects: 329
Study: 33150389

Group type: EXPERIMENTAL
Intervention: Exercise intervention (n = 54)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Usual care (control group, n = 49)
Number of subjects: 103
Study: 32707605

Group type: EXPERIMENTAL
Intervention: PEG‐IFNα‐2a plus adefovir dipivoxil (ADV)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: PEG‐IFNα‐2a alone
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil alone
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: PEG‐IFNα‐2a (retreatment)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil (retreatment)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Cirrhosis
Number of subjects: 60

Group type: COMPARATOR
Intervention: Noncirrhotic
Number of subjects: 60
Study: 35613989

Group type: EXPERIMENTAL
Intervention: S-ketamine
Number of subjects: 80

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 80
Study: 34739196

Group type: EXPERIMENTAL
Intervention: Daprodustat
Number of subjects: 3872

Group type: COMPARATOR
Intervention: Darbepoetin alfa
Number of subjects: 3872
Study: 35847015

Group type: EXPERIMENTAL
Intervention: Yinhuapinggan granules (YHPG)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study: 33317139

Group type: EXPERIMENTAL
Intervention: Preworkout multi-ingredient (PREW)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Carbohydrate (CHO)
Number of subjects: 14
Study: 35182721

Group type: EXPERIMENTAL
Intervention: Atezolizumab 1200 mg i.v. on day 1 with neoadjuvant carboplatin and nab-paclitaxel
Number of subjects: 280

Group type: COMPARATOR
Intervention: No atezolizumab with neoadjuvant carboplatin and nab-paclitaxel
Number of subjects: 280
Study: 34295720

Group type: EXPERIMENTAL
Intervention: Music group (listening to preferred music during the procedure)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Non-music group (no music during the procedure)
Number of subjects: 91
Study: 37246680

Group type: EXPERIMENTAL
Intervention: High-intensity aerobic training (Intensity 80-90% of target heart rate) for 8 weeks
Number of subjects: 42

Group type: COMPARATOR
Intervention: Low-intensity aerobic training (Intensity 40-60% of target heart rate)
Number of subjects: 42
Study: 35331959

Group type: EXPERIMENTAL
Intervention: NSPT + PDT
Number of subjects: 46

Group type: COMPARATOR
Intervention: NSPT
Number of subjects: 46
Study: 32861716

Group type: EXPERIMENTAL
Intervention: C2238 ANP allele (homozygous CC)
Number of subjects: 557

Group type: COMPARATOR
Intervention: TT wild type genotype
Number of subjects: 557
Study: 32505198

Group type: EXPERIMENTAL
Intervention: Accurate estimators
Number of subjects: 714

Group type: EXPERIMENTAL
Intervention: Male under-estimators
Number of subjects: 714

Group type: EXPERIMENTAL
Intervention: Inaccurate perception groups (male)
Number of subjects: 714

Group type: EXPERIMENTAL
Intervention: Self-help score (women)
Number of subjects: 714

Group type: EXPERIMENTAL
Intervention: Self-help score (men)
Number of subjects: 714

Group type: EXPERIMENTAL
Intervention: Self-help behaviours
Number of subjects: 714
Study: 34585595

Group type: EXPERIMENTAL
Intervention: loteprednol‐etabonate 0.5% twice daily for 14 days tapered to once daily for 14 days, and then twice weekly for 28 days
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: loteprednol‐etabonate 0.5%
Number of subjects: 10

Group type: COMPARATOR
Intervention: NaCl 0.9%
Number of subjects: 10
Study: 32722454

Group type: EXPERIMENTAL
Intervention: 8% carbohydrate (CHO) solution (5 mL/kg/bw)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo (PLA) solution (flavour and appearance-matched, 5 mL/kg/bw)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: CHO ingestion
Number of subjects: 15
Study: 36476442

Group type: EXPERIMENTAL
Intervention: CRISP method with flipped classroom approach
Number of subjects: 120

Group type: COMPARATOR
Intervention: Lecture-based learning method
Number of subjects: 120
Study: 34462574

Group type: EXPERIMENTAL
Intervention: Polygenic risk score (PRS) for schizophrenia
Number of subjects: 29878

Group type: EXPERIMENTAL
Intervention: Thalamic NDI
Number of subjects: 29878
Study: 32457004

Group type: EXPERIMENTAL
Intervention: Upper extremity aerobic exercise training (50-80% of maximal heart rate), 15-45 min/day, 3 days a week for 6 weeks
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Upper extremity aerobic exercise training
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (alternating active upper extremity exercises for the same period)
Number of subjects: 22
Study: 35033117

Group type: EXPERIMENTAL
Intervention: Audio Computer‐Assisted Self Interviewing (ACASI) combined with face‐to‐face interviews
Number of subjects: 0

Group type: COMPARATOR
Intervention: Face‐to‐face interviews
Number of subjects: 0
Study: 89012353

Group type: EXPERIMENTAL
Intervention: Hepatitis B immune globulin and vaccine on schedule
Number of subjects: 3464

Group type: EXPERIMENTAL
Intervention: Hepatitis B immune globulin and vaccine off schedule
Number of subjects: 3464

Group type: COMPARATOR
Intervention: Not applicable (overall population)
Number of subjects: 3464
Study: 34699967

Group type: EXPERIMENTAL
Intervention: Albuterol/budesonide (180/160 µg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Albuterol/budesonide
Number of subjects: 60
Study: 32562651

Group type: EXPERIMENTAL
Intervention: Ever-married rate for those aged 15–19 years
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Age-specific fertility rate (ASFR) for those aged 15–19 years
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ever-married rate for women aged 20–24 years
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ASFR for women aged 20–24 years
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ever-married rate for girls and women in rural areas aged 15–19 years
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ASFR for girls and women in rural areas aged 15–19 years
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Education level impact on ever-married rate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Geographic disparities in marriage and childbearing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Protective association of education against adolescent childbearing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Risk factors for adolescent marriage and childbearing
Number of subjects: 0
Study: 35786028

Group type: EXPERIMENTAL
Intervention: Custom-made functional foot orthoses
Number of subjects: 66

Group type: COMPARATOR
Intervention: Flat cushioning insoles
Number of subjects: 66
Study: 34397827

Group type: EXPERIMENTAL
Intervention: Inhalation anesthesia (IH)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia (TIVA)
Number of subjects: 104
Study: 37665297

Group type: EXPERIMENTAL
Intervention: Encorafenib + binimetinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34570180

Group type: EXPERIMENTAL
Intervention: Methylphenidate (10 mg, twice daily)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 32197128

Group type: EXPERIMENTAL
Intervention: Somatosensory stimulation on below-level insensate body regions
Number of subjects: 11
Study: 33940082

Group type: EXPERIMENTAL
Intervention: Severe sleep restriction (SR; 2 hr sleep opportunity/night)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Adequate sleep (AS; 7–9 hr sleep opportunity/night)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Severe sleep restriction (SR)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Adequate sleep (AS)
Number of subjects: 18
Study: 32175680

Group type: EXPERIMENTAL
Intervention: Co-administration of edaravone with taurine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Taurine
Number of subjects: 0
Study: 35371949

Group type: EXPERIMENTAL
Intervention: Physiotherapy with muscle training (MT) of the postpartum pelvic floor
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control group (no rehabilitation)
Number of subjects: 92
Study: 33562090

Group type: EXPERIMENTAL
Intervention: Fermented powdered soy product (12.5 g each, 2 packets daily)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Germinated brown rice control powder (isoenergic)
Number of subjects: 27
Study: 34100215

Group type: EXPERIMENTAL
Intervention: HD including a single bout of hybrid intradialytic exercise
Number of subjects: 21

Group type: COMPARATOR
Intervention: Standard HD
Number of subjects: 21
Study: 34543581

Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 681

Group type: COMPARATOR
Intervention: Morphine
Number of subjects: 681
Study: 36228310

Group type: EXPERIMENTAL
Intervention: 5 mg/day (Group 1)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 2.5 mg/day (Group 2)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 5 mg/week (Group 3)
Number of subjects: 90

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 90
Study: 33988093

Group type: EXPERIMENTAL
Intervention: Peri-operative platelet-rich plasma intervention
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control
Number of subjects: 56
Study: 35533500

Group type: EXPERIMENTAL
Intervention: Plasma neurofilament light chain protein (NfL) levels on day one
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Plasma NfL levels on day one
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Day one NfL levels
Number of subjects: 0
Study: 33045216

Group type: EXPERIMENTAL
Intervention: Netarsudil 0.02% ophthalmic solution
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 33781066

Group type: EXPERIMENTAL
Intervention: Biodentine (Septodont, Saint Maur des Fossés, France)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Mineral Trioxide Aggregate (Rootdent MTA, TehnoDent, Russia)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Fuji IX GP (GC Corporation, Tokyo, Japan)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Positive control group (unfilled retrocavities)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Negative control group (sealed with flowable composite material)
Number of subjects: 70
Study: 36099688

Group type: EXPERIMENTAL
Intervention: Acceptance-enhanced behavior therapy for TTM (AEBT‐TTM)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Psychoeducation and supportive therapy (PST)
Number of subjects: 85
Study: 34050429

Group type: EXPERIMENTAL
Intervention: Thoracic epidural analgesia (TEA) with continuous epidural bupivacaine and sufentanil infusion
Number of subjects: 50

Group type: COMPARATOR
Intervention: Paravertebral analgesia (PVA) with continuous paravertebral bupivacaine infusion and intravenous morphine
Number of subjects: 50
Study: 32846929

Group type: EXPERIMENTAL
Intervention: K-diet
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 10
Study: 35590794

Group type: EXPERIMENTAL
Intervention: 0.9% sodium chloride
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 5% glucose
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Ringer’s solution
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control (no liquid administered)
Number of subjects: 18
Study: 34656955

Group type: EXPERIMENTAL
Intervention: 200 mg MOFs daily for 3 months
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo daily for 3 months
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: 200 mg MOFs
Number of subjects: 97
Study: 34332956

Group type: EXPERIMENTAL
Intervention: Ketamine 0.5 mg/kg bolus then 0.12 mg/kg/h infusion for the first 24 hours postoperative
Number of subjects: 90

Group type: COMPARATOR
Intervention: Ketamine 0.5 mg/kg and Mg sulfate 50 mg/kg, then ketamine 0.12 mg/kg/h and Mg sulfate 8 mg/kg/h infusions for the first 24 hours postoperative
Number of subjects: 90
Study: 34428440

Group type: EXPERIMENTAL
Intervention: Text message-based support (4 texts per week for 6 months) covering diet, physical activity, smoking, general cardiovascular health, and medication adherence.
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Text message-based support (4 texts per week for 6 months).
Number of subjects: 246

Group type: COMPARATOR
Intervention: Standard care only (control group).
Number of subjects: 246
Study: 33721365

Group type: EXPERIMENTAL
Intervention: Letibotulinum toxin A (LeBA)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Onabotulinum toxin A (OnBA)
Number of subjects: 240
Study: 32609422

Group type: EXPERIMENTAL
Intervention: eGFRCys
Number of subjects: 7217

Group type: EXPERIMENTAL
Intervention: eGFR Cr-Cys
Number of subjects: 7217

Group type: EXPERIMENTAL
Intervention: eGFRCr-Cys-B2M
Number of subjects: 7217

Group type: EXPERIMENTAL
Intervention: All filtration markers combined
Number of subjects: 7217

Group type: EXPERIMENTAL
Intervention: Major macrovascular events
Number of subjects: 7217

Group type: EXPERIMENTAL
Intervention: Microvascular events
Number of subjects: 7217

Group type: EXPERIMENTAL
Intervention: All-cause mortality
Number of subjects: 7217
Study: 35637272

Group type: EXPERIMENTAL
Intervention: 60 mg oral methylphenidate
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 33534742

Group type: EXPERIMENTAL
Intervention: Hand-dug well (HDW)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 14
Study: 33825964

Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg twice daily
Number of subjects: 5
Study: 32039864

Group type: EXPERIMENTAL
Intervention: Educational intervention (four face-to-face training sessions and two virtual training sessions using educational videos)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (no educational intervention)
Number of subjects: 67
Study: 34636314

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (Botox)
Number of subjects: 11
Study: 33690132

Group type: EXPERIMENTAL
Intervention: Manual compression
Number of subjects: 80

Group type: COMPARATOR
Intervention: Mechanical compression (using radial TR band)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Mechanical compression
Number of subjects: 80
Study: 34653245

Group type: EXPERIMENTAL
Intervention: OVX836 (30 µg, 90 µg, or 180 µg)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 33341367

Group type: EXPERIMENTAL
Intervention: Multi-domain cognitive training (MDCT) for 12 weeks (24 sessions)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Multi-domain cognitive training (MDCT)
Number of subjects: 32
Study: 34843383

Group type: EXPERIMENTAL
Intervention: Diet and exercise program
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: Exercise program
Number of subjects: 415

Group type: COMPARATOR
Intervention: Control group (electronic osteoarthritis information)
Number of subjects: 415
Study: 32331244

Group type: EXPERIMENTAL
Intervention: Reduced energy diet (1200 kcal/day)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Standard diet (2000 kcal/day)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Standard antenatal GDM management (insulin/metformin)
Number of subjects: 500
Study: 36074245

Group type: EXPERIMENTAL
Intervention: DHA supplementation during pregnancy
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 300
Study: 34403046

Group type: EXPERIMENTAL
Intervention: 20% fly ash + 40% vermicompost
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 40% fly ash + 40% vermicompost
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Moderate concentrations of fly ash and vermicompost
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 40% soil + 20% fly ash + 40% vermicompost
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Addition of vermicompost
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Addition of fly ash
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Marginal addition of fly ash to vermicompost
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Treatment effects on pH
Number of subjects: 21
Study: 33270066

Group type: EXPERIMENTAL
Intervention: Straumann SLActive
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Astra OsseoSpeed
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Thommen Implant System
Number of subjects: 30
Study: 36171046

Group type: EXPERIMENTAL
Intervention: OnTrack system for arm and hand rehabilitation (12 weeks duration)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: OnTrack system for arm and hand rehabilitation
Number of subjects: 12
Study: 32853672

Group type: EXPERIMENTAL
Intervention: Azithromycin (AZM) in addition to hydroxychloroquine (HCQ) and lopinavir/ritonavir (LPV/r)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Hydroxychloroquine (HCQ) and lopinavir/ritonavir (LPV/r)
Number of subjects: 111